IMPORTANT PRESCRIBER & PATIENT NOTICE This preparation is compounded only when the prescribing practitioner documents that the FDA-approved product does not meet the patients medical needs (e.g., different strength, excipient profile, or delivery route)
Take our 3-minute eligibility quiz, and a clinician will review your answers
Semaglutide GLP-1 injections work by mimicking a hormone called incretin that functions by aiding the pancreas in releasing accurate levels of insulin to combat a rise in sugar levels in the blood
Assessing the presence of eating disorders in patients seeking treatment for obesity The high prevalence of eating disorders among patients seeking treatment for obesity highlights the need for thorough screening in this population
Professional guidelines from organizations such as the American Gastroenterological Association and the Endocrine Society recommend that weight management treatment, including pharmacotherapy, be provided within the context of ongoing clinical care with regular monitoring
The trans-epithelial transport of semaglutide was examined in cell monolayers of gastric epithelium (NCI-N87) with and without SNAC exposure